Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sebastian Theurich

Showing results (131-140 of 142) with videos related to

Pageof 15
Sort By:
European Journal of Cancer (Oxford, England : 1990)|July 15, 2025
Navigating rare cancer care: Patient-reported insights into patient journeys, time to diagnosis, decision-making and care coordination from a national cross-sectional study in GermanyLaura Oestreich, Friederike Mumm, Theresia Pichler, et al.
Oncotarget|July 16, 2014
Characterization of tumor-associated B-cell subsets in patients with colorectal cancerAlexander Shimabukuro-Vornhagen, Hans A Schlößer, Luise Gryschok, et al.
Scientific Reports|May 18, 2026
Glucocorticoids induce a phagocytic C1Q+ macrophage phenotype primed for IFNγ-dependent CXCL9 secretionAlexandra S Triebig, Tanja Maier, Paul Schwarzlmueller, et al.
Blood|July 25, 2022
T-cell exhaustion induced by continuous bispecific molecule exposure is ameliorated by treatment-free intervalsNora Philipp, Maryam Kazerani, Alyssa Nicholls, et al.
Frontiers in Oncology|June 26, 2026
A multi-center cross-sectional study to explore cancer patients' views on facilitators and barriers for the implementation of oncological exercise therapyDominik Morlok, Laura Bieniosek, Hansjörg Baurecht, et al.
International Journal of Cancer|August 25, 2021
Early weight loss is an independent risk factor for shorter survival and increased side effects in patients with metastatic colorectal cancer undergoing first-line treatment within the randomized Phase III trial FIRE-3 (AIO KRK-0306)Lian Liu, Nicole Tonya Erickson, Ingrid Ricard, et al.
Oncoimmunology|July 29, 2016
Immune checkpoints programmed death 1 ligand 1 and cytotoxic T lymphocyte associated molecule 4 in gastric adenocarcinomaHans A Schlößer, Uta Drebber, Michael Kloth, et al.
Leukemia|November 16, 2019
Influence of obesity and gender on treatment outcomes in patients with chronic lymphocytic leukemia (CLL) undergoing rituximab-based chemoimmunotherapyMoritz Fürstenau, Georg Hopfinger, Sandra Robrecht, et al.
BMC Cancer|April 16, 2025
Advancing the implementation of quality-assured oncological exercise therapy in Germany: protocol for the IMPLEMENT projectMirko Brandes, Anika Berling-Ernst, Hansjoerg Baurecht, et al.
Blood|July 10, 2025
Boosting CAR T-Cell Efficacy by Blocking Proteasomal Degradation of Membrane AntigensLeonie Rieger, Kilian Irlinger, Franziska Füchsl, et al.
Pageof 15

Showing results (131-140 of 142) with videos related to

Sort By:
Pageof 15
European Journal of Cancer (Oxford, England : 1990)|July 15, 2025
Navigating rare cancer care: Patient-reported insights into patient journeys, time to diagnosis, decision-making and care coordination from a national cross-sectional study in GermanyLaura Oestreich, Friederike Mumm, Theresia Pichler, et al.
Oncotarget|July 16, 2014
Characterization of tumor-associated B-cell subsets in patients with colorectal cancerAlexander Shimabukuro-Vornhagen, Hans A Schlößer, Luise Gryschok, et al.
Scientific Reports|May 18, 2026
Glucocorticoids induce a phagocytic C1Q+ macrophage phenotype primed for IFNγ-dependent CXCL9 secretionAlexandra S Triebig, Tanja Maier, Paul Schwarzlmueller, et al.
Blood|July 25, 2022
T-cell exhaustion induced by continuous bispecific molecule exposure is ameliorated by treatment-free intervalsNora Philipp, Maryam Kazerani, Alyssa Nicholls, et al.
Frontiers in Oncology|June 26, 2026
A multi-center cross-sectional study to explore cancer patients' views on facilitators and barriers for the implementation of oncological exercise therapyDominik Morlok, Laura Bieniosek, Hansjörg Baurecht, et al.
International Journal of Cancer|August 25, 2021
Early weight loss is an independent risk factor for shorter survival and increased side effects in patients with metastatic colorectal cancer undergoing first-line treatment within the randomized Phase III trial FIRE-3 (AIO KRK-0306)Lian Liu, Nicole Tonya Erickson, Ingrid Ricard, et al.
Oncoimmunology|July 29, 2016
Immune checkpoints programmed death 1 ligand 1 and cytotoxic T lymphocyte associated molecule 4 in gastric adenocarcinomaHans A Schlößer, Uta Drebber, Michael Kloth, et al.
Leukemia|November 16, 2019
Influence of obesity and gender on treatment outcomes in patients with chronic lymphocytic leukemia (CLL) undergoing rituximab-based chemoimmunotherapyMoritz Fürstenau, Georg Hopfinger, Sandra Robrecht, et al.
BMC Cancer|April 16, 2025
Advancing the implementation of quality-assured oncological exercise therapy in Germany: protocol for the IMPLEMENT projectMirko Brandes, Anika Berling-Ernst, Hansjoerg Baurecht, et al.
Blood|July 10, 2025
Boosting CAR T-Cell Efficacy by Blocking Proteasomal Degradation of Membrane AntigensLeonie Rieger, Kilian Irlinger, Franziska Füchsl, et al.
Pageof 15